The EU's drugs regulator has said that blood clots should be listed as a "very rare" side effect of the Johnson & Johnson Covid-19 vaccine.

The European Medicines Agency said in a statement that it had found a "possible link" between the jab and clots.

But it added that the benefits of the Covid-19 vaccine outweighed the risks.

Out of more than seven million people who have received the jab in the US, eight people developed rare blood clots, including one person who died.

The cases of clotting in the US "occurred in people under 60 years of age within three weeks after vaccination, the majority in women", the regulator said.

(BBC)